IBD Center Conference

5th Annual Baylor University Medical Center IBD Center Conference

April 25, 2020

Baylor Charles A. Sammons Cancer Center • Dallas, Texas

About the Conference

Physician leadership roles are vastly changing in the healthcare industry as they are being introduced more to the financial components of their departments. This CME course will engage physicians in discussion regarding the evolution of financial responsibility and introduce them to the collection and revenue cycle process.

As a result of attending this activity, the participants should be able to:

  • Incorporate strategies to increase health care efficiency and promote healthcare innovation
  • Support the needs of the patient while being cognizant of cost and efficiency issues
  • Recognize strategic approaches for successful leadership role in institutional role or private practice
  • Collaborative to improve the healthcare system and provide equitable, affordable health care globally
  • Assimilate new communication skills with a focus on ethical considerations


Statement of Need

The two main Inflammatory Bowel Diseases (IBD), Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, progressive idiopathic inflammatory disorders of the gastrointestinal (GI) tract. CD can affect any part of the GI tract, whereas UC affects the colon only.

A study using data from 2003-2004 estimated that approximately 436,000 Americans have CD and 512,000 have UC 1. The prevalence of CD was estimated at 151 per 100,000, while UC prevalence was estimated 178 per 100,000 1. A subsequent study using 2009 data estimated that 1,171,000 Americans have IBD (565,000 CD and 593,000 UC) 2. The protracted nature of these diseases exerts a major toll on patients in terms of need for chronic medical therapies, hospitalizations, surgery, health-related quality of life, economic productivity and social functioning. CD is responsible for $3.48 billion in total costs in the United States 3

Management of IBD is a complex, multidisciplinary process, made all the more difficult by the clinical heterogeneity of IBD and the lack of comparative effectiveness studies. Numerous studies have demonstrated practice variation, for example in the use of anti-inflammatory therapies, vaccinations and surgery. A recent study found significant variation among seven major US referral centers in the treatment of CD with immunomodulators 4. The practice variation points to areas of potential improvement in the quality of IBD care.

  1. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, Finkelstein JA. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol. 2007 Dec;5(12):1424-9.
  2. Kappelman MD, Moore KR, Allen JK, Cook SF. Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population. Dig Dis Sci. 2013; 58(2): 519–525.
  3. Ganz ML, Sugarman R, Wang R, Hansen BB, Håkan-Bloch J. The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey. Inflamm Bowel Dis. 2016 May;22(5):1032-41.
  4. Ananthakrishnan AN, Kwon J, Raffals L, Sands B, Stenson WF, McGovern D, Kwon JH, Rheaume RL, Sandler RS. Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States. Clin Gastroenterol Hepatol. 2015 Jun;13(6):1197-200.

Program Agenda

Presentation materials, when available, may be downloaded in pdf format.

Saturday, April 25, 2020

  • 7 a.m.

    Registration and continental breakfast

  • 7:50 a.m.

    Welcome and course overview

  • Session One

    8 a.m.

    Management of Crohn’s Disease in 2020: State of the Art

  • 8:25 a.m.

    Management of Ulcerative Colitis in 2020: State of the Art

    Millie D. Long, MD, MPH

  • 8:50 a.m.

    Limitations of Current Evidence

    Thomas A. Ullman, MD

  • 9:15 a.m.

    New Trial Designs, Network Meta-Analyses, Propensity Scores: What the Clinician Needs to Know

  • 9:40 a.m.

    Panel Discussion/Q&A

  • 10 a.m.

    Morning Break/Exhibits

  • Section 2

    10:20 a.m.

    Surgical Prophylaxis of Recurrent Crohn’s Disease

  • 10:40 a.m.

    Staged Approach for Surgery for Ulcerative Colitis: When and Why

  • 11 a.m.

    Management of Intra-Abdominal Abscesses in Crohn’s Disease

    Kimberly Persley, MD

  • 11:20 a.m.

    Treating Functional Abdominal Pain in IBD

    Linda A. Feagins, MD

  • 11:40 a.m.

    Panel Discussion/Q&A

  • 12 p.m.

    Lunch and Case Discussions

  • Session 3

    1 p.m.

    Overcoming Vaccine Hesitancy in IBD Patients

  • 1:20 p.m.

    Update on Metabolic Bone Disease

  • 1:40 p.m.

    Update on Clostridioides Difficile

  • 2 p.m.

    Caring for the Patient with Severe IBD and Severe Liver Disease

  • 2:20 p.m.

    Panel Discussion/Q&A

  • 2:40 p.m.


Accreditation and Credit Designation


The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians

The. A Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of __ AMA PRA Category I Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

*This activity meets Texas requirements for 1 hour of Ethical/Professional Responsibility Education.


The conference is held at the Baylor Charles A. Sammons Cancer Centeron the Baylor University Medical Center at Dallas campus.

The Baylor University Medical Center campus encompasses many hospital buildings, programs and office buildings. Avariety of parking options are available, including self-park, valet, covered parking and private lots.

Download campus map

Baylor Charles A. Sammons Cancer Center
Tom Hunt Auditorium, 10th Floor
3410 Worth Street
Dallas, TX 75246




PA, NP, RN, Other


GI Fellows/Residents


Baylor Scott & White GI Fellows/Residents 


Cancellation and Refund Policy

We request that all conference attendees pre-register to assure the availability of conference materials.
No refunds will be provided for cancellations received after March 29, 2019.
Refunds (minus $25 administration fee) will be provided to registrants who cancel their registration in writing up to March 29, 2019.
The conference organizers will not be responsible for reimbursement of airline fees and other accommodation expenses.

Evaluation and Credit Claim

Evaluate the speakers and claim continuing education credit.

Contact Us

For additional information, please contact:
Tajuanekja Davis
Phone: 214.820.6440

Check out all of our upcoming learning opportunities